Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)

Name: Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)
License: Public Domain

Shanghai Changzheng Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

gastric cancer, immunotherapy, anlotinib, toripalimab

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 332742
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.